Esperion Therapeutics, Inc. (ESPR)
3.27
-0.08
(-2.39%)
USD |
NASDAQ |
Mar 02, 16:00
3.27
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Accounts Payable (Quarterly) : 77.51M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Nektar Therapeutics | 15.56M |
| Rigel Pharmaceuticals, Inc. | 3.846M |
| Harrow, Inc. | 18.99M |
| AnaptysBio, Inc. | 2.893M |
| ACADIA Pharmaceuticals, Inc. | 10.90M |